EUVIMEDEUVIMED entdecken
Crossref

Once-weekly HIV pill performs as well as daily treatment in phase III study

Pharmaceutical Journal · 2026

DOI: 10.1211/pj.2026.1.422349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Journal, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A once-weekly tablet could maintain HIV control as well as existing daily treatment, according to the results of a phase III international study. The study’s findings were published in the New England Journal of Medicine on 29 July 2026 and presented at the AIDS 2026 conference, held in Rio de Janeiro, Brazil, on 26–31 July […]

Zitieren

APA

(2026). Once-weekly HIV pill performs as well as daily treatment in phase III study. Pharmaceutical Journal. https://doi.org/10.1211/pj.2026.1.422349

Vancouver

Once-weekly HIV pill performs as well as daily treatment in phase III study. Pharmaceutical Journal. 2026. doi:10.1211/pj.2026.1.422349

BibTeX
@article{euvimed2026,
  title = {Once-weekly HIV pill performs as well as daily treatment in phase III study},
  journal = {Pharmaceutical Journal},
  year = {2026},
  doi = {10.1211/pj.2026.1.422349}
}
Kostenlos starten →